Schizophrenia and the risk of fractures: A systematic review and comparative meta-analysis

General Hospital Psychiatry

Volumn 37, Issue 2, 2015, Pages 126-133

  Stubbs, Brendon ^a   Gaughran, Fiona ^b   Mitchell, Alex J ^c   De Hert, Marc ^d   Farmer, Ross ^b   Soundy, Andrew ^e   Rosenbaum, Simon ^f,g   Vancampfort, Davy ^d,h  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

Fracture; Fragility fracture; Osteoporosis; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; FRACTURE; HEALTH CARE COST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OBSERVATIONAL STUDY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREDICTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SCHIZOPHRENIA; SYSTEMATIC REVIEW; COMORBIDITY; COMPARATIVE STUDY; FRACTURES, BONE;

COMORBIDITY; FRACTURES, BONE; HUMANS; SCHIZOPHRENIA;

EID: 84924917465     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.01.004     Document Type: Article

References (57)

1. Kanis J.A. Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359(9321):1929-1936.
2. Kanis J., McCloskey E., Johansson H., Cooper C., Rizzoli R., Reginster J.Y. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013, 24(1):23-57.
3. Hummer M., Malik P., Gasser R.W., et al. Osteoporosis in patients with schizophrenia. Am J Psychiatr 2005, 162(1):162-167.
4. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007, 116(5):317-333.
5. Stubbs B. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density. J Psychiatr Ment Health Nurs 2009, 16(9):838-842.
6. De Hert M., Correll C.U., Bobes J., et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011, 10(1):52-77.
7. Stubbs B., De Hert M., Sepehry A.A., et al. A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatr Scand 2014, 130(6):470-486.
8. Oderda L.H., Asche C.V., Pepper G.A., Leipzig R.M., Tasic D. Drugs and fall risk: an updated systematic review. Commun Nurs Res 2009, 42:412.
9. Kishimoto T., De Hert M., Carlson H.E., Manu P., Correll C.U. Osteoporosis and fracture risk in people with schizophrenia. Curr Opin Psychiatry 2012, 25(5):415-429.
10. Soundy A., Wampers M., Probst M., et al. Physical activity and sedentary behaviour in outpatients with schizophrenia: a systematic review and meta-analysis. . . including commentary by Attux C, Leutwyler H, and Strohle A. Int J Ther Rehabil 2013, 20(12):588-596.
11. Vancampfort D., Probst M., Sweers K., Maurissen K., Knapen J., De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand 2011, 123(6):423-430.
12. Stubbs B., Mitchell A.J., De Hert M., Correll C.U., Soundy A., Stroobants M., et al. The prevalance and moderators of clinical pain in people with schizophrenia: a systematic review and large scale meta-analysis. Schizophr Res 2014, 160(1-3):1-8.
13. Deandrea S., Lucenteforte E., Bravi F., Foschi R., La Vecchia C., Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 2010, 21(5):658-668.
14. Stubbs B., Binnekade T., Eggermont L., Sepehry A.A., Patchay S., Schofield P. Pain and the risk for falls in community-dwelling older adults: systematic review and meta-analysis. Arch Phys Med Rehabil 2014, 95(1):175-187.
15. Vancampfort D., Wampers M., Mitchell A.J., et al. A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry 2013, 12(3):240-250.
16. Mitchell A.J., Vancampfort D., De Herdt A., Yu W., De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull 2013, 39(2):295-305.
17. Janghorbani M., Van Dam R.M., Willett W.C., Hu F.B. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007, 166(5):495-505.
18. Dazzan P., Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 2002, 181(Suppl. 43):s50-s57.
19. Rosso I.M., Bearden C.E., Hollister J.M., et al. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 2000, 26(2):367-378.
20. Abraham G., Halbreich U., Friedman R.H., Josiassen R.C. Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res 2003, 59(1):17-18.
21. Halbreich U., Rojansky N., Palter S., et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995, 57(5):485-491.
22. Halbreich U., Palter S. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 1996, 22(3):447-454.
23. Sattui S.E., Saag K.G. Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 2014, 10(10):592-602.
24. Holt R.I.G. Osteoporosis in people with severe mental illness: a forgotten condition. Maturitas 2010, 67(1):1-2.
25. Javaid M.K., Holt R.I.G. Understanding osteoporosis. J Psychopharmacol 2008, 22(2, Suppl):38-45.
26. Menendez M.E., Neuhaus V., Bot A.G.J., Vrahas M.S., Ring D. Do psychiatric comorbidities influence inpatient death, adverse events, and discharge after lower extremity fractures?. Clin Orthop Relat Res 2013, 471(10):3336-3348.
27. Hartikainen S., Lönnroos E. Use of sedatives and hypnotics, antidepressants and benzodiazepines in older people significantly increases their risk of falls. Evid Based Med 2010, 15(2):59.
28. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
29. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Clin Trials 2009, 6(7):1-6.
30. Association AP Diagnostic and statistical manual of mental disorders - DSM-IV-TR 2000, American Psychiatric Association. 4th ed.
31. Organisation Wh The ICD-10 classification of mental and behavioural disorders - diagnostic criteria for research 1993.
32. Wells G., Shea B., O'Connell D., Peterson Jea The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [accessed 01/12/2013]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
33. Higgins J.P.T., S G. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane collaboration 2011, [Available from www.cochrane-handbook.org].
34. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
35. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
36. Sørensen H.J., Jensen S.O.W., Nielsen J. Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis. Eur Neuropsychopharmacol 2013, 23(8):872-878.
37. Tsai K., Lee C.C., Chou Y.M., Shen S.P., Su C.Y., et al. The risks of major osteoporotic fractures in patients with schizophrenia: a population-based 10-year follow-up study. Schizophr Res 2014, 159(2-3):322-388.
38. Lai S.-W., Lin C.-L., Liao K.-F. Higher incidence of hip fracture in newly diagnosed schizophrenic patients in Taiwan. Libyan J Med 2013, 8:1-2.
39. Jung D.-U., Kelly D.L., Oh M.-K., et al. Bone mineral density and osteoporosis risk in older patients with schizophrenia. J Clin Psychopharmacol 2011, 31(4):406-410.
40. Bishop J.R., Alexander B., Lund B.C., Klepser T.B. Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacotherapy 2004, 24(4):515-521.
41. Kelly D.L., Myers C.S., Abrams M.T., et al. The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders. Osteoporos Int 2011, 22(4):1133-1143.
42. Howard L., Kirkwood G., Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry 2007, 190(2):129-134.
43. Bolton J.M., Metge C., Lix L., Prior H., Sareen J., Leslie W.D. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 2008, 28(4):384-391.
44. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359(9321):1929.
45. Takahashi T., Uchida H., John M., et al. The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: findings from a longitudinal observational cohort. Schizophr Res 2013, 147(2/3):383-386.
46. Peuskens J., Pani L., Detraux J., De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs 2014, 28(5):421-453.
47. Vancampfort D., Probst M., De Herdt A., et al. An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study. BMC Psychiatry 2013, 13:5.
48. Vancampfort D., Probst M., Scheewe T., et al. Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia. Psychiatry Res 2013, 207(1-2):25-32.
49. Sherrington C., Whitney J.C., Lord S.R., Herbert R.D., Cumming R.G., Close J.C.T. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 2008, 56(12):2234-2243.
50. Rosenbaum S., Tiedemann A., Sherrington C., Curtis J., Ward P.B. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. J Clin Psychiatry 2014, 75(9):964-974.
51. Naci H., Ioannidis J.P.A. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ 2013, 347:f5577-f.
52. Snowden C.P., Prentis J., Jacques B., et al. Cardiorespiratory fitness predicts mortality and hospital length of stay after major elective surgery in older people. Ann Surg 2013, 257(6):999-1004.
53. Vancampfort D., Guelinckx H., De Hert M., et al. Reliability and clinical correlates of the Astrand-Rhyming sub-maximal exercise test in patients with schizophrenia or schizoaffective disorder. Psychiatry Res 2014, 220(3):778-783.
54. Stubbs B., Probst M., Soundy A., et al. Physiotherapists can help implement physical activity programmes in clinical practice. Br J Psychiatry 2014, 204(2):164.
55. Lord O., Malone D., Mitchell A.J. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry 2010, 32(5):519-543.
56. Mitchell A.J., Pereira I.E., Yadegarfar M., Pepereke S., Mugadza V., Stubbs B. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br J Psychiatry 2014 Dec, 205(6):428-435.
57. Kanis J.A., McCloskey E.V., Johansson H., Oden A., Ström O., Borgström F. Development and use of FRAX in osteoporosis. Osteoporos Int 2010, 21(Suppl. 2):S407-S413.